Perspective Therapeutics (CATX) Receivables - Accured (2022 - 2025)

Perspective Therapeutics has disclosed Receivables - Accured across 3 years of filings, most recently posting $1.0 million for Q4 2025.

• In Q4 2025, Receivables - Accured rose 16.25% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (up 16.25% YoY), while the FY2025 annual figure was $1.0 million, up 16.25% from the prior year.
• Receivables - Accured came in at $1.0 million for Q4 2025 at Perspective Therapeutics, up from $880000.0 in the prior quarter.
• In the past five years, Receivables - Accured ranged from a high of $1.0 million in Q4 2025 to a low of $109000.0 in Q4 2022.
• Average Receivables - Accured over 3 years is $670666.7, with a median of $880000.0 recorded in 2024.
• The largest YoY upside for Receivables - Accured was 16.25% in 2025 against a maximum downside of 16.25% in 2025.
• Over 3 years, Receivables - Accured stood at $109000.0 in 2022, then soared by 707.34% to $880000.0 in 2024, then rose by 16.25% to $1.0 million in 2025.
• Per Business Quant data, the three most recent Receivables - Accured figures were $1.0 million in Q4 2025, $880000.0 in Q4 2024, and $109000.0 in Q4 2022.